20th Anniversary

  • News
  • Inquiry
  • Contact Us for business opportunity
  • Recruitment information
  • Japanese
  • English
  • HOME
  • Vision
    vision
    Introducing the vision of SymBio
    • CEO message
      CEO message
    • SymBio in 2 minutes
      SymBio in 2 minutes
    • Corporate culture
      Corporate culture
    • Charter of Corporate Conduct
      Charter of Corporate Conduct
    • Books
      Books
  • Business model
    Business model
    The following is an introduction to the business model of SymBio.
    • Business domain and profit model
      Business domain and profit model
    • Proprietary drug discovery business
      Proprietary drug discovery business
    • Global business
      Global business
    • Joint research with academia
      Joint research with academia
    • Key person interview
      Key person interview
  • Pipeline
    Pipeline
    SymBio introduces the pipeline of pharmaceuticals.
    • Pipeline overview
      Pipeline overview
    • SyB V-1901
      SyB V-1901
    • SyB L-1701/L-1702
      SyB L-1701/L-1702
      SyB L-0501
      SyB L-0501
  • IR information
    IR information
    Toward a patient-centered, supportive relationship among scientists, doctors, government, and shareholders.
    • Latest IR information
      Latest IR information
    • IR news
      IR news
    • CEO message
      CEO message
    • financial highlights
    • IR library
    • Analyst
      report
    • video library
    • IR Calendar
    • General Meeting of Shareholders Information
    • Basic stock information
    • Electronic public notice
  • About SymBio
    About SymBio
    Company Information of SymBio Pharmaceuticals
    • Company Profile
      Company Profile
    • Origin of company name
      Origin of company name
    • History
      History
    • Officer introduction
    • Organization chart
    • Corporate
      governance
    • compliance
      about
    • on transparency
      Information disclosure
    • SDGs initiatives
  • News
  • Inquiry
  • Contact Us for business opportunity
  • Recruitment information
  • Japanese English
  1. TOP
  2. Vision
  3. CEO message
  4. Fuminori Yoshida remarks

Fuminori Yoshida remarks

  • It all started with a will
  • dreams come true
  • Greetings from the listing
  • Dream of SymBio pharmaceuticals
  • Second founding
  • CEO talks
  • Regarding entry into delisting grace period
    - CEO message
  • Video release of interim financial results briefing
    - CEO message

vision

  • CEO message
  • SymBio in 2 minutes
  • Corporate culture
  • Charter of Corporate Conduct
  • Book introduction
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals
  • Inquiry
  • Contact Us for business opportunity
  • Personal information protection policy, etc.
  • Privacy Notice for Clinical Trials in UK
  • About the use of the site
  • site map
Copyright © SymBio Pharmaceuticals Limited.